Understanding drug responses to individual genetic makeup is crucial for several stages of drug development. As more data becomes available on patients’ genes, clinicians and researchers will be better equipped to select personalized treatments for their patients. Hence, molecular genetic testing has become a significant component of the drug development process.
Today several pharmaceutical companies outsource studies such as PK/PD interactions and BA/BE assessments to bioanalytical services. PK/PD modeling in drug development helps researchers assess individual drug responses of a particular patient population. Thus, PK/PD modeling is an essential bioanalytical solution required for the robust development of pharmaceutical drug products. The current article highlights the role of bioanalytical services CROs in the field of molecular genetic testing. This article will help sponsors evaluate laboratory partners while choosing Biolabs near them.
Bioanalytical services for molecular genetic testing
The rise in the development of complex drug products, vaccines, biologics, and cell and gene therapies has pushed platforms and assays to their limits. During such challenging times, bioanalytical services CROs have emerged as indispensable resources for drug development companies. This resourcefulness is especially true for an ever-evolving field of molecular genetic testing.
Bioanalytical services readily meet increased demands for more robust bioanalytical and analytical support. . As the business model for all bioanalytical services depends on highly specialized bioanalytical solutions, they always stay updated for newer clients and projects. Besides, bioanalytical services heavily invest in expertise and sites around the globe to provide quick and flexible solutions as soon and efficiently as possible.
As molecular genetic testing is a relatively new field, sponsors can drive their program with the expertise of bioanalytical services CROs. The primary benefit of collaborating with CROs is their substantial experience working on several drug molecules and novel therapeutics and can translate that expertise into custom bioanalytical solutions for your molecular genetic testing needs.
Bioanalytical services offer customized molecular genetic services and conduct several genomic-based assays. These assays can support sponsors at all stages of drug development through singleplex and multiplex assay formats. Their services include analyzing complex components such as mRNA, siRNA, and antisense oligos through viral vectors. Moreover, most of these bioanalytical services can isolate and purify RNA and DNA from numerous study samples, such as body fluids, tissues, and cell cultures. Besides, the extraction process is generally automated to provide high-quality results.
Today gene and cell therapy products are at the forefront of solving several issues related to disease and medical conditions. Bioanalytical CROs have comprehensive molecular genetic solutions to help drug developers produce plasmid, viral and cell-based drug products. Regulatory bodies require detailed biodistribution and shedding data for cell and gene products. Bioanalytical CROs have extensive experience conducting biodistribution and shedding studies that meet all regulatory expectations. Besides, they can use different study matrices to assess cell and gene compounds in several animal models. Hence, even though molecular genetic testing is a relatively novel field, bioanalytical services are an ideal option for taking forward your genetic testing needs.
